healthcare · APOLLOHOSP
Apollo Hospitals
Apollo Hospitals: PE above historical average. NARROW LEADERSHIP regime.
Price
₹8,988
Price 2026-07-30
5 day
+2.07%
Short-term move
1 month
+3.52%
Medium-term
Regime
NARROW LEADERSHIP
62% confidence
Market cap
₹127.1k Cr
neutral sector flow
Market Intelligence Analyst
Understand today's market in about 2 minutes.
“How does today's NARROW LEADERSHIP regime affect Apollo Hospitals (APOLLOHOSP) in the healthcare sector?”
Price chart
₹8,903
+23.26% over period
About Apollo Hospitals
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics, urology, organ transplantation, pulmonology, obstetrics and gynecology, internal medicine, vascular surgery, pediatrics, cosmetology, emergency medicine, bariatric surgery, general surgery, colorectal surgery, dentistry, nephrology, dermatology, endocrinology, preventive medicine, interventional radiology, ophthalmology, and integrative medicine, as well as robotic surgery and genomics. The company also provides project consultancy, medical educational institutes, Medvarsity for e-learning, and research services, as well as acts as an agent for life, general, and health insurance. In addition, it operates hospitals, pharmacies, primary care clinics, and diagnostic centers; short stay facilities, boutique birthing centers, multi-special...
At a Glance
RSI pattern warning
RSI oversold bounces for this stock succeeded only 0% of the time (avg -8.2% over 14 days) — not a reliable pattern.
52-week position
Trading at 100.4% of 52-week high
Technicals
RSI 14
59.9
Trend
uptrend
50 DMA
Above
200 DMA
Above
Key metrics
P/E ratio
65.4
57th pct · 7 quarterly points (limited history)
P/B
13.4
ROE
21.5%
Strong profitability — 21.5% return on equity
Market cap
₹127.1k Cr
Revenue growth
1810.0% YoY
Promoter
28.0%
52-week range
₹6,696.5 – ₹8,950
100.4% of high
RSI (14)
59.9
uptrend
vs 50 DMA
Above
DMA ₹8,596.19
Fundamental
100/100
STRONG
Trust
95/100
Verification
Coverage
100/100
HIGH
Quick Take
Apollo Hospitals scores 100/100 on fundamentals (strong). Apollo Hospitals: PE above historical average. NARROW LEADERSHIP regime.
Fundamental Score: 100/100 · STRONG · 2 signals detected
DuPont Analysis
ROE 19.6% broken into three drivers. Each shows how efficiently the company generates returns.
ROE of 19.55% is moderate efficiency-driven and stable. Net margin 7.6%, asset turnover 1.1x, leverage 2.3x.
What This Means
Net margin of 7.6% means the company keeps ₹7.6 as profit for every ₹100 of revenue. This is a moderate-margin business. Asset turnover of 1.10x means the company efficiently uses its assets to generate revenue. Leverage of 2.3x means the company uses moderate debt. Returns are primarily driven by operations, not borrowing.
Margin Structure
Gross
47.9%
Operating
12.1%
Net
7.6%
Gross margin 47.9% → operating margin 12.1% → net margin 7.6%. Margins are IMPROVING. Strong pricing power with stable gross margins suggests the improvement is from operating leverage — sustainable.
Financial Health
Earnings Quality
STRONGCash flow covers net income 1.5x — earnings are HIGH QUALITY. The company converts profit to cash efficiently.
Debt Sustainability
COMFORTABLEInterest covered 6.5x — very comfortable. Debt service is not a concern. Debt/EBITDA at 2.2x is moderate.
Free Cash Flow
STRONGFCF margin at 3.6% — moderate. Generating cash after investments.
Peer comparison
| Stock | Price | 5D | P/E | ROE | Rev growth | Mcap |
|---|---|---|---|---|---|---|
| MAXHEALTH Max Healthcare | ₹1,124.8 | +3.7% | 76 | 14.3% | 1220% | ₹1.1L Cr |
| FORTIS Fortis Healthcare | ₹948.85 | +0.7% | 70.3 | 11% | 1780% | ₹73.4k Cr |
| ASTERDM Aster DM Healthcare | ₹814 | +3.8% | 104.9 | 10.1% | 1820% | ₹40.8k Cr |
| NH Narayana Hrudayalaya | ₹2,080.3 | +4.9% | 50.2 | 19.8% | 7580% | ₹40.7k Cr |
| LALPATHLAB Dr. Lal Pathlabs | ₹1,878.8 | +11.7% | 55.7 | 21.5% | 1660% | ₹28.1k Cr |
| APOLLOHOSP Apollo Hospitals | ₹8,988 | +1.4% | 65.4 | 21.5% | 1810% | ₹1.3L Cr |
Key Watchpoints
Breaks above ₹9437 (+5%)
Trend reversal confirmation
Breaks below ₹8539 (-5%)
Further downside risk
PE reverts to median of 64.2 (7 quarterly points (limited history))
Valuation normalization
Healthcare sector entering leadership
Sector rotation signal
Detected Patterns
Risk Flags
Liquidity squeeze. Company may struggle to meet short-term obligations without refinancing.
Profits are from core operations, not one-offs. High quality.
Mean recommendation: 1.4/5 (1=Strong Buy, 5=Strong Sell). Institutional confidence is high.
⚠️ 1 critical + 0 warning flags. Exercise caution.
Data Quality
News Correlation
50 articles scanned for fundamental themes
